Researchers delineated the phenotypic and functional defects in NK cells of high-risk B- and T- cell acute lymphoblastic leukemia (ALL) patients using mass, flow, and in silico cytometry, with the goal of further elucidating the role of NK cells in sustaining ALL regression.
[Blood]
6445218 {6445218:9BIRS5V4} apa 50 1 163078 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-74fc73cbe0a34f8eb967f3a14291264d%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%229BIRS5V4%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Duault%20et%20al.%22%2C%22parsedDate%22%3A%222021-06-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EDuault%2C%20C.%2C%20Kumar%2C%20A.%2C%20Taghi%20Khani%2C%20A.%2C%20Lee%2C%20S.%20J.%2C%20Yang%2C%20L.%2C%20Huang%2C%20M.%2C%20Hurtz%2C%20C.%2C%20Manning%2C%20B.%2C%20Ghoda%2C%20L.%20Y.%2C%20McDonald%2C%20T.%2C%20Lacayo%2C%20N.%20J.%2C%20Sakamoto%2C%20K.%20M.%2C%20Carroll%2C%20M.%20P.%2C%20Tasian%2C%20S.%20K.%2C%20Marcucci%2C%20G.%2C%20Yu%2C%20J.%2C%20Caligiuri%2C%20M.%20A.%2C%20Maecker%2C%20H.%20T.%2C%20%26amp%3B%20Swaminathan%2C%20S.%20%282021%29.%20Activated%20Natural%20Killer%20Cells%20Predict%20Poor%20Clinical%20Prognosis%20in%20High-risk%20B-%20and%20T-%20cell%20Acute%20Lymphoblastic%20Leukemia.%20%3Ci%3EBlood%3C%5C%2Fi%3E%2C%20%3Ci%3Eblood.2020009871%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1182%5C%2Fblood.2020009871%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1182%5C%2Fblood.2020009871%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3D9BIRS5V4%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Activated%20Natural%20Killer%20Cells%20Predict%20Poor%20Clinical%20Prognosis%20in%20High-risk%20B-%20and%20T-%20cell%20Acute%20Lymphoblastic%20Leukemia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%22%2C%22lastName%22%3A%22Duault%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anil%22%2C%22lastName%22%3A%22Kumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adeleh%22%2C%22lastName%22%3A%22Taghi%20Khani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sung%20June%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lu%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Min%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Hurtz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%22%2C%22lastName%22%3A%22Manning%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucy%20Y.%22%2C%22lastName%22%3A%22Ghoda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tinisha%22%2C%22lastName%22%3A%22McDonald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Norman%20J%22%2C%22lastName%22%3A%22Lacayo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathleen%20M%22%2C%22lastName%22%3A%22Sakamoto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20P.%22%2C%22lastName%22%3A%22Carroll%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20K%22%2C%22lastName%22%3A%22Tasian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guido%22%2C%22lastName%22%3A%22Marcucci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jianhua%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20A%22%2C%22lastName%22%3A%22Caligiuri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Holden%20T.%22%2C%22lastName%22%3A%22Maecker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srividya%22%2C%22lastName%22%3A%22Swaminathan%22%7D%5D%2C%22abstractNote%22%3A%22B-%20and%20T-%20cell%20acute%20lymphoblastic%20leukemia%20%28B%5C%2FT-ALL%29%20may%20be%20refractory%20or%20recur%20after%20therapy%20by%20suppressing%20host%20anti-cancer%20immune%20surveillance%20mediated%20specifically%20by%20natural%20killer%20%28NK%29%20cells.%20We%20delineated%20the%20phenotypic%20and%20functional%20defects%20in%20NK%20cells%20of%20high-risk%20B%5C%2FT-ALL%20patients%20using%20mass%2C%20flow%2C%20and%20in%20silico%20cytometry%2C%20with%20the%20goal%20of%20further%20elucidating%20the%20role%20of%20NK%20cells%20in%20sustaining%20ALL%20regression.%20We%20found%20that%2C%20compared%20to%20normal%20counterparts%2C%20NK%20cells%20in%20B%5C%2FT-ALL%20patients%20are%20less%20cytotoxic%2C%20but%20exhibit%20an%20activated%20signature%20characterized%20by%20high%20CD56%2C%20high%20CD69%2C%20production%20of%20activated%20NK-origin%20cytokines%2C%20and%20calcium%20signaling.%20We%20demonstrated%20that%20defective%20maturation%20of%20NK%20cells%20into%20cytotoxic%20effectors%20prevents%20NK%20cells%20of%20ALL%20patients%20from%20lysing%20NK-sensitive%20targets%20as%20efficiently%20as%20normal%20NK%20cells.%20Additionally%2C%20we%20showed%20that%20NK%20cells%20in%20ALL%20are%20exhausted%2C%20which%20is%20likely%20caused%20by%20their%20chronic%20activation.%20We%20found%20that%20increased%20frequencies%20of%20activated%20cytokine-producing%20NK%20cells%20are%20associated%20with%20increased%20disease%20severity%20and%20independently%20predict%20poor%20clinical%20outcome%20in%20ALL%20patients.%20Our%20studies%20highlight%20the%20benefits%20of%20developing%20NK%20cell%20profiling%20as%20a%20diagnostic%20tool%20to%20predict%20clinical%20outcome%20in%20patients%20with%20ALL%20and%20underscore%20the%20clinical%20potential%20of%20allogeneic%20NK%20infusions%20to%20prevent%20ALL%20recurrence.%22%2C%22date%22%3A%22June%202%2C%202021%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1182%5C%2Fblood.2020009871%22%2C%22ISSN%22%3A%220006-4971%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1182%5C%2Fblood.2020009871%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-06-03T16%3A57%3A16Z%22%7D%7D%5D%7D
Duault, C., Kumar, A., Taghi Khani, A., Lee, S. J., Yang, L., Huang, M., Hurtz, C., Manning, B., Ghoda, L. Y., McDonald, T., Lacayo, N. J., Sakamoto, K. M., Carroll, M. P., Tasian, S. K., Marcucci, G., Yu, J., Caligiuri, M. A., Maecker, H. T., & Swaminathan, S. (2021). Activated Natural Killer Cells Predict Poor Clinical Prognosis in High-risk B- and T- cell Acute Lymphoblastic Leukemia. Blood, blood.2020009871. https://doi.org/10.1182/blood.2020009871 Cite